Calyptus Pharma Appoints Amit Patel to Board of Directors

Monday, June 11, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

PRINCETON, N.J., June 11, 2018 /PRNewswire/ -- Calyptus Pharmaceuticals Inc. ("Calyptus"), a private pharmaceutical company

focused on the needs of hospitals, community clinics, specialty and retail pharmacies, today announced the appointment of Amit Patel to its Board of Directors.

Sujeet Singh, CEO of

Calyptus, stated, "Amit brings with him a successful track record and deep experience in the healthcare industry including generic and specialty pharmaceuticals. His experience with publicly-traded, private equity-backed, and start-up companies in various capacities – as an executive, investor, and advisor – will be invaluable to Calyptus." (Go to: https://www.calyptuspharma.com/copy-of-team for Amit's profile)

Commenting on his appointment, Amit said, "I welcome the opportunity to join the Calyptus Board at the early stages of the company's growth potential.  I look forward to helping advance Calyptus' mission and supporting the interests of its customers, colleagues, partners and investors."

Founded in 2017, Calyptus is developing a portfolio of sterile products (generic ANDAs and specialty 505(b)2s) that resolve technological complexity, create accelerated regulatory pathways, bridge unmet medical needs and overcome market access barriers.

ABOUT CALYPTUS PHARMACEUTICALS

Calyptus Pharma is a pharmaceutical company whose mission is to improve lives of patients by increasing access and affordability of quality medicines.

Calyptus Pharmaceuticals Inc. Empowering Healthcare

CONTACT Name: Shubhayu Sinharoy, COO Email: 196933@email4pr.com Phone: 269-873-0430 Website: www.calyptuspharma.com

Cision View original content:http://www.prnewswire.com/news-releases/calyptus-pharma-appoints-amit-patel-to-board-of-directors-300663947.html

SOURCE Calyptus Pharmaceuticals



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store